HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rita Humeniuk Selected Research

tirabrutinib

1/2022Semi-Mechanistic PK/PD Modeling and Simulation of Irreversible BTK Inhibition to Support Dose Selection of Tirabrutinib in Subjects with RA.
1/2021Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma.
1/2020Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rita Humeniuk Research Topics

Disease

5COVID-19
04/2022 - 01/2020
5Neoplasms (Cancer)
01/2022 - 06/2008
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
12/2020 - 01/2020
2Colorectal Neoplasms (Colorectal Cancer)
05/2009 - 05/2009
1Rheumatoid Arthritis
01/2022
1Severe Acute Respiratory Syndrome
01/2021
1B-Cell Lymphoma (Lymphoma, B Cell)
01/2021
1HIV Infections (HIV Infection)
01/2021
1Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2020
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2020
1Diarrhea
12/2020
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2018
1Fatigue
11/2018
1Sarcoma (Soft Tissue Sarcoma)
11/2018
1Malaria
12/2016
1Carcinogenesis
05/2014
1Neoplasm Metastasis (Metastasis)
05/2009
1Gastrointestinal Neoplasms (Gastrointestinal Cancer)
05/2009
1Breast Neoplasms (Breast Cancer)
06/2008
1Carcinoma (Carcinomatosis)
06/2008
1Acute Promyelocytic Leukemia
01/2003

Drug/Important Bio-Agent (IBA)

5remdesivirIBA
04/2022 - 01/2020
5Pharmaceutical PreparationsIBA
01/2022 - 05/2009
3tirabrutinibIBA
01/2022 - 01/2020
3idelalisibIBA
01/2021 - 01/2020
2Agammaglobulinaemia Tyrosine KinaseIBA
01/2022 - 01/2020
2RNA (Ribonucleic Acid)IBA
01/2021 - 05/2009
26- (1H- indazol- 6- yl)- N- (4- morpholinophenyl)imidazo(1,2- a)pyrazin- 8- amineIBA
01/2021 - 01/2020
2Messenger RNA (mRNA)IBA
05/2009 - 05/2009
2Fluorouracil (Carac)FDA LinkGeneric
05/2009 - 05/2009
1GS-704277IBA
01/2021
1GS-441524 triphosphateIBA
01/2021
1NucleosidesIBA
01/2021
1EnzymesIBA
01/2021
1GS-441524IBA
01/2021
1vesatolimodIBA
01/2021
1triphosphoric acid (triphosphate)IBA
01/2021
1Transaminases (Aminotransferases)IBA
12/2020
1Phosphatidylinositols (Phosphatidylinositol)IBA
12/2020
1Antiviral Agents (Antivirals)IBA
01/2020
1N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA
11/2018
1trametinibIBA
11/2018
1Alanine Transaminase (SGPT)IBA
11/2018
1PlatinumIBA
11/2018
1Antimalarials (Antimalarial Agents)IBA
12/2016
15-fluorouridineIBA
05/2009
1Proteins (Proteins, Gene)FDA Link
05/2009
1Leucovorin (Folinic Acid)FDA Link
05/2009
1DNA (Deoxyribonucleic Acid)IBA
05/2009
1Thymidylate SynthaseIBA
05/2009
1DecitabineFDA Link
05/2009
1uridine monophosphate kinaseIBA
05/2009
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
05/2009
1Membrane Proteins (Integral Membrane Proteins)IBA
06/2008
1Azacitidine (5 Azacytidine)FDA Link
06/2008
1Conditioned Culture MediaIBA
06/2008
1Type II DNA Topoisomerases (Topoisomerase II)IBA
01/2003

Therapy/Procedure

2Therapeutics
01/2021 - 02/2009
1Drug Therapy (Chemotherapy)
11/2018